Blood immune cells from people with HIV on antiviral regimens that contain tenofovir alafenamide (TAF) and tenofovir disoproxil fumarate (TDF) have differential metabolic signatures

By sjmartinez • February 27, 2023

Ritou E, Satta S, Petcherski A, Daskou M, Sharma M, Vasilopoulos H, Murakami E, Shirihai OS, Kelesidis T. Blood immune cells from people with HIV on antiviral regimens that contain tenofovir alafenamide (TAF) and tenofovir disoproxil fumarate (TDF) have differential metabolic signatures. Metabolism. 2023 Apr;141:155395. doi: 10.1016/j.metabol.2022.155395. Epub 2023 Jan 14. PMID: 36842771.

Tags: Antivirals, Endocrinology, HIV, Immune cells, Infectious Diseases, Metabolism, mitochondria, Publications, Tenofovir alafenamide (TAF), Tenofovir disoproxil fumarate (TDF)

Menopausal Transition and Thyroid Function Trajectories: A Large-Scale Longitudinal Study of Healthy Women

Hayashi S, Fukui S, Leung AM, Noto H, Inoue K. Menopausal Transition and Thyroid Function Trajectories: A Large-Scale Longitudinal Study of Healthy Women. J Clin[...]

E. Dale Abel, MD, PhD Awarded Jamaica’s Order of Distinction, Commander Class

The UCLA Department of Medicine is proud to announce that E. Dale Abel, MD, PhD, chair and executive medical director of the Department of Medicine[...]

Incidence, Risk Factors, and Survival Implications of Immune-Related Adverse Events in Patients With Metastatic Breast Cancer

Baclig NV, Chengappa M, Soliman AJ, Jacob S, LeVee A, Fisch S, Face C, Chaudhry S, Idossa D, Poonacha T, Huppert L, Quintal L, Melisko[...]